CARE OF LUNG CANCER PATIENTS WITH SIMULTANEOUS CHEMORADIOTHERAPY AND SOME RELATED FACTORS AT K HOSPITAL IN 2023

Thị Thu Nga Vũ, Quốc Đạt Phạm, Thị Hải Anh Nguyễn

Main Article Content

Abstract

Concurrent chemotherapy and radiotherapy for lung cancer is considered the current standard treatment for cases in the local stage, in areas without distant metastases that are not amenable to surgery. Caring for these patients is unique, requiring nurses to not only closely monitor the progress of the disease but also closely listen, share, and actively encourage the patient's spirit so that the patient can trust and feel at ease. treatment center. Objective: Analysis of results of care for lung cancer patients with concurrent chemotherapy and radiotherapy and some related factors at K Hospital in 2023. Subjects and methods: Designed a cross-sectional descriptive study on 110 lung cancer patients receiving concurrent chemotherapy and radiotherapy, collecting information on patient care according to nursing procedures in treatment departments at 3 the time from the start of treatment until the patient is discharged from the hospital. Results: The percentage of patients with good care results is 85.4%. Factors such as gender, duration and number of cigarettes smoked, treatment compliance, comorbidities and patient BMI are statistically significantly related to patient care outcomes.

Article Details

References

1. Sung H., Ferlay J., Siegel R.L. và cộng sự. (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin, 71(3), 209–249.
2. Dogan T., Tugut N., và Golbasi Z. (2013). The Relationship Between Sexual Quality of Life, Happiness, and Satisfaction with Life in Married Turkish Women. Sex Disabil, 31(3), 239–247.
3. Chen T., Zhou F., Jiang W. và cộng sự. (2019). Age at diagnosis is a heterogeneous factor for non-small cell lung cancer patients. Journal of Thoracic Disease, 11(6).
4. Phan Lê Thắng (2017), Nghiên cứu điều trị ung thư phổi không tế bào nhỏ giai đoạn II, IIIA bằng phối hợp phẫu thuật triệt căn và hóa xạ trị bổ trợ, Luận án Tiến sĩ Y học, Đại học Y Hà Nội, Hà Nội.
5. Nguyễn Quang Trung, Nguyễn Khánh Toàn, Phạm Thị Hường và cộng sự. (2023). Đánh giá kết quả điều trị ung thư phổi không tế bào nhỏ giai đoạn III bằng phác đồ hóa chất Paclitaxel Carboplatin kết hợp đồng thời với xạ trị. Tạp chí Y học Việt Nam, 2(527), 234–239.
6. Doubova S.V. và Pérez-Cuevas R. (2020). Supportive care needs and quality of care of patients with lung cancer in Mexico: A cross-sectional study. European Journal of Oncology Nursing, 49, 101857.